Abstract: The present study was designed to compare the susceptibility to carbon tetrachloride (CCl 4 )-induced hepatotoxicities of the different liver lobes of rats which had been subjected to pretreatment with phenobarbital sodium (PB) or β-naphthoflavone (BNF). A detailed investigation was done to determine whether the susceptibility to CCl 4 hepatotoxicities was correlated with hepatic cytochrome P450 (CYP) activities in the different liver lobes. Male Wistar rats were given a single oral administration of CCl 4 (0.1 mL/kg, dissolved in liquid paraffin) or vehicle alone following three daily intraperitoneal injections of PB (40 mg/kg, dissolved in sterile saline) or BNF (40 mg/kg, suspended in sesame oil). One day after the CCl 4 administration, all animals were necropsied, and liver samples were obtained from the left and median lobes. Each sample was used for histopathological examination and 7-alkoxycoumarin O-dealkylase activity assay to evaluate the CYP activity. All the CCl 4 -treated animals revealed typical liver damage, such as the presence of ballooning degeneration and necrosis in centrilobular hepatocytes. PB pretreatment remarkably enhanced the extent of the liver damage, which was greater in the median lobe than the left lobe. BNF pretreatment only slightly enhanced the extent of the liver damage, which was also greater in the median lobe. These results indicate the different susceptibilities of rat liver lobes to CCl 4 -induced hepatotoxicities enhanced by pretreatment with PB or BNF. Moreover, the heterogeneity of the CYP activities enhanced by PB pretreatment was closely correlated with the susceptibility to CCl 4 -induced hepatotoxicities in the different liver lobes, although that by BNF pretreatment was not. (J Toxicol Pathol 2004; 17: 223-230) 
Introduction
Carbon tetrachloride (CCl 4 ) is a well-established hepatotoxic chemical, the toxicity of which arises from reactive intermediates formed in the course of enzymatic bioactivation [1] [2] [3] . The enzymes involved in the bioactivation are cytochrome P-450 (CYP) enzymes 4, 5 , whose activities are among the most important factors determining the extent of the liver damage caused by CCl 4 .
In a previous paper, we reported that CYP activities assessed by measurement of 7-alkoxycoumarin Odealkylase activities, which reflect various CYP isoforms 6 , showed apparent heterogeneity among the liver lobes of rats, that is, the activities in the median and right lobes were higher than those in the left lobe 7 . We also demonstrated that the susceptibility to CCl 4 -induced hepatotoxicities (CCl 4 hepatotoxicities) differed significantly among the various lobes of the rat liver, and that these differences were closely correlated with the heterogeneity of hepatic CYP activities in the different liver lobes 8 . These findings indicate that the heterogeneity of hepatic CYP activities in the different liver lobes might be one of the factors causing the lobar variations in CCl 4 hepatotoxicities. However, there were no other reports in the literature on investigation of the correlations between the susceptibility to CCl 4 hepatotoxicities and the hepatic CYP activities in the different liver lobes. Previously, we also reported alterations of hepatic enzyme distribution among the rat liver lobes following pretreatment with hepatic enzyme-inducing agents, phenobarbital (PB) or β-naphthoflavone (BNF) 7 . In the present study, we therefore compared the susceptibility to CCl 4 hepatotoxicities of the different liver lobes of rats enhanced by pretreatment with PB or BNF. Moreover, we also investigated in detail whether the susceptibility to CCl 4 hepatotoxicities was correlated with hepatic CYP activities in the different liver 
Materials and Methods

Chemicals
Carbon tetrachloride (CCl 4 ), phenobarbital sodium (PB) and 5, 6-benzoflavone (β-naphthoflavone, BNF) were all purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan).
Animals
After approval of the study by the Institutional Animal C a r e a n d U s e C o m m i t t e e o f S h i o n o g i R e s e a r c h Laboratories, 9-week-old male Wistar strain rats were purchased from Japan SLC, Inc. (Shizuoka, Japan) and housed in metal cages (3 or 4 rats per cage), on absorbent paper (Paper Clean) for bedding in an environmentcontrolled room kept at 23 ± 3°C, 30-70% humidity, with a 12-hour lighting period (light on: 8:00-20:00). The animals were fed with a conventional diet (CA-1, Clea Japan Inc., Tokyo, Japan). After a one-week acclimatization period, the animals were used for the following experiment.
Experimental design
Twenty animals were allocated into the following six groups: (i) treated with vehicle only (vehicle alone, n = 3), (ii) treated with PB only (PB alone, n = 3), (iii) treated with BNF only (BNF alone, n = 3), (iv) treated with CCl 4 only (CCl 4 alone, n = 3), (v) pretreated with PB and treated with CCl 4 (PB + CCl 4 , n = 4) and (vi) pretreated with BNF and treated with CCl 4 (BNF + CCl 4 , n = 4). Animals were given a single oral administration of CCl 4 (0.1 mL/kg, dissolved in liquid paraffin) or the vehicle alone following the pretreatment of three daily intraperitoneal injections of PB (40 mg/kg, dissolved in sterile 0.9% saline) or BNF (40 mg/ kg, suspended in sesame oil). All animals were sacrificed 24 hr after the administration of CCl 4 .
Sampling sites
As in our previous reports 7, 8 , the liver was divided into six different sites (#1 to #6) shown in Fig. 1 . Liver samples were obtained from the left (#2) and the median (#5) lobes, which showed the lowest and highest susceptibilities to CCl 4 hepatotoxicities, respectively, in our previous study 8 .
Preparation of liver microsomes
Liver microsomes were prepared as previously reported [7] [8] [9] . Briefly, excised livers were minced in ice-cold 0.154 M KCl solution and homogenized using a Potter-type Teflon glass homogenizer. The microsomal fraction was isolated by 1-hour centrifugation at 105,000 g of the supernatant resulting from 10-minute centrifugation of the homogenate at 15,000 g. The pellet was resuspended in 0.25 M sucrose containing 50 mM Tris-HCl buffer (pH 7.4) and used as the microsomal fraction.
Assay for 7-alkoxycoumarin O-dealkylase activities
The activities of microsomal 7-alkoxycoumarin Odealkylase [7-methoxycoumarin O-demethylase (MCOD), 7 -e t ho x yc ou m a r i n O -dee thylase (ECOD) and 7-propoxycoumarin O-depropylase (PCOD)] were determined by fluorometric measurement of 7-hydroxycoumarin produced in the reaction mixture during the incubation. Each sample was measured once. The detailed procedure has been described elsewhere 7, 9 .
Histopathological examination
Liver samples were fixed in 10% neutral buffered formalin, dehydrated in alcohol and embedded in paraffin. Paraffin sections were prepared and stained by a routine method with hematoxylin and eosin. Frozen sections were stained with Oil red O for lipids. The entire slide was scanned, and the histopathological changes were arbitrarily scored according to the following scoring system 8 modified from Bioulac et al. 10 : (a) necrosis, -to ++++ (-, no necrosis; ±, focal necrosis of 1-3 cells per lesion; +, focal necrosis of more than 3 cells per lesion; ++, zonal necrosis around central vein; +++, zonal necrosis in central and intermediary zones; ++++, massive confluent necrosis); (b) ballooning degeneration, -to +++ (-, no ballooning; ±, few ballooned cells per lesion; +, more than 10 ballooned cells per lesion; ++, 1 or 2 rows of ballooned cells around the necrotic zone, per lesion; +++, more than 2 rows of ballooned cells around the necrotic zone, per lesion); (c) fatty degeneration, -to ++ (-, no steatosis; ±, slight; +, moderate; ++, severe); and (d) hypertrophy, -to ++ (-, no hypertrophy; ±, slight; +, moderate; ++, severe).
Statistical analysis
Significant differences of the MCOD, ECOD and PCOD activities between the CCl 4 -alone group and vehiclealone group were assessed, based on analysis by Student's ttest. Significant differences among the vehicle-alone, PB (or BNF)-alone and PB + CCl 4 (or BNF + CCl 4 ) groups were analyzed by one-way analysis of variance, followed by a multiple comparisons test using the least significant difference method. Comparisons of each activity between the lobes were performed using the paired-sample t-test.
Results were considered significant when the P value was less than 0.05.
Results
Hepatic 7-alkoxycoumarin O-dealkylase activities
Effect of CCl 4 treatment alone: The results of the assay for the 7-alkoxycoumarin O-dealkylase activities in CCl 4 -treated rats are shown in Fig. 2 . In the vehicle-alone group, the MCOD, ECOD and PCOD activities in the median lobe were significantly higher [25% (P<0.05), 36% (P<0.05) and 35% (P<0.01), respectively] than those in the left lobe. The CCl 4 treatment alone resulted in decreases in these activities in both lobes. Significant decreases in these activities in the CCl 4 -alone group were found only in the median lobe as compared to those in the vehicle-alone group, whereas only slight decreases were observed in the left lobe. There were no significant differences in these activities between the two lobes in the CCl 4 -alone group.
Effect of CCl 4 treatment following pretreatment with PB: The results of the assay of CCl 4 -treated rats with PB pretreatment are shown in Fig. 3 . PB pretreatment alone specifically enhanced the MCOD, ECOD and PCOD activities in both lobes, regardless of the substitution of the alkyl group of the 7-alkoxycoumarin. Activities of the MCOD, ECOD and PCOD in the PB-alone group were significantly higher [39% (P<0.05), 43% (P<0.05) and 40% (P<0.05), respectively] in the median lobe than in the left lobe. In contrast, the PB + CCl 4 treatment resulted in marked decreases in these activities in both lobes, with the extent of the decreases being stronger in the median lobe. More specifically, the MCOD activity in the median lobe was significantly lower [42% (P<0.05)] than that in the left lobe, although the ECOD and PCOD activities were also lower [40% and 37%, respectively] without any significant difference.
Effect of CCl 4 treatment following pretreatment with BNF: The results of the assay for CCl 4 -treated rats with BNF pretreatment are shown in Fig. 4 . BNF pretreatment alone markedly enhanced the ECOD and PCOD activities in both lobes, but not the MCOD activity. Although the MCOD activity in the median lobe was significantly higher [34% (P<0.01)] than that in the left lobe, the ECOD and PCOD activities in the median lobe were lower [19% (P<0.05) and 17%, respectively], but no significant difference was observed in the PCOD activity. Thus, the BNF + CCl 4 treatment resulted in only slight decreases in these activities in both lobes with a similar distribution pattern to the BNF-alone group.
Histopathological changes
Histopathological findings for the livers are summarized in Table 1 . Although the extent of the liver damage differed slightly among the animals, a similar pattern was obtained for those in the same experimental group.
In all control groups, no abnormal histopathological changes were observed with the exception of centrilobular hypertrophy of hepatocytes in the PB-alone group. There were no histopathological differences between the two lobes in these control groups.
All the CCl 4 -treated animals revealed typical liver damage with obvious differences between the two lobes as shown in Fig. 5 . In the CCl 4 -alone group, focal necrosis was observed in both lobes, but the extent of the lesions was greater in the median lobe (arbitrary score: +) than in the left lobe (±). Furthermore, ballooning degeneration around the necrotic zones was observed only in the median lobe (++) (Fig. 5A and 5B). PB pretreatment remarkably enhanced the extent of the lesions with more expanded zonal or massive confluent necrosis and ballooning degeneration around the necrotic lesions in the median lobe (necrosis: ++++, ballooning: +++) and the left lobe, but to a somewhat lesser extent (necrosis: +++, ballooning: +++) ( Fig. 5C and 5D ).
On the other hand, BNF pretreatment only slightly enhanced the extent of the lesions, which was also greater in the median lobe (necrosis: + to ++, ballooning: ++ to +++) than in the left lobe (necrosis: ± to +, ballooning: + to ++) ( Fig. 5E and 5F). Oil red O staining showed fatty deposition in the cytoplasm of the hepatocytes, which was observed in both lobes of all the CCl 4 -treated groups, but no apparent differences were detectable between the two lobes.
Discussion
Previously, we demonstrated that susceptibility to CCl 4 hepatotoxicities differed among the various liver lobes of rats, and higher susceptibilities to CCl 4 hepatotoxicities were specifically observed in the median and right lobes as compared with the left lobe 8 . Several other studies have also reported on lobar variation in CCl 4 hepatotoxicities. Lawson and Pound 11 suggested higher susceptibility to CCl 4 hepatotoxicities in the right lobe, and our previous histological results 8 generally agreed with theirs. In addition to these two reports, Low et al. 12 also assessed the lobar variation in CCl 4 hepatotoxicities, using an approach of systematic random sampling coupled with quantitative morphometry. They found lobar variation in the extent of the damage, but no tendency for damage to a certain lobe was evident because the lobe showing the most severe damage differed among animals. They also pointed out that true assessment of the severity of liver damage following a xenobiotic challenge could only be achieved adequately by their systematic random sampling protocol 12, 13 . Although this protocol is useful for elimination of any bias in evaluating lobar differences and the value of quantitative morphology, the evaluating method was not suitable for our present study, as we needed to estimate the functional and morphological changes using limited liver samples. We therefore used our previously reported sampling method The reasons underlying the lobar variation in CCl 4 hepatotoxicities are not fully understood. As one of the causative factors of lobar variation, we have focused on the heterogeneity of hepatic CYP activities in the different lobes. Therefore, in the present study, we investigated in detail the correlation between the susceptibility to CCl 4 hepatotoxicities and hepatic CYP activities in the different liver lobes.
Our present results show higher O-dealkylase activities in the median lobe of the vehicle-alone group regardless of the substitution of the alkyl group of 7-alkoxycoumarin. PB pretreatment alone resulted in remarkable increases of the Odealkylase activities with heterogeneity in the hepatic CYP activities. Furthermore, the substrate specificity was almost the same as that of the vehicle-alone group. On the other hand, BNF pretreatment alone showed marked increases of the ECOD and PCOD activities, but a slight decrease for the MCOD activity. Interestingly, higher MCOD activity in the median lobe was obtained even after pretreatment with BNF. However, the ECOD and PCOD activities were enhanced preferentially in the left lobe. These results suggest functional heterogeneity of CYP enzymes among liver lobes which is responsive to various hepatic enzyme-inducing agents as previously reported 7 . It is well known that an exposure to CCl 4 causes dosage-dependent decreases in hepatic CYP enzymes followed by hepatocellular damage 14, 15 . Our present results also show decreases in the O-dealkylase activities depended on the extent of the lesions in all the CCl 4 -treated animals. In the CCl 4 -alone group, only slight decreases in these activities were observed in both lobes, with the more extensive decreases in the median lobe. Moreover, the extent of the lesions was also greater in the median lobe than in the left lobe. Therefore, the more extensive lesions in the median lobe due to CCl 4 treatment alone were closely correlated with the higher activities of CYP in the lobe.
The hepatotoxicity of CCl 4 is dependent upon its bioactivation by several isoforms of CYP enzymes to one or more toxic intermediates [1] [2] [3] . CYP2E1 is believed to be the (3) - (3) - (3) - (3) - (3) - (3) - (3) -(3) PB-alone - (3) - (3) - (3) - (3) - (3) - (3) ± (2), + (1) ± (1), + (2) BNF-alone - (3) - (3) - (3) - (3) - (3) - (3) - (3) - (3) CCl 4 treatment CCl 4 -alone ± (3) + (3) - (3) ++ (3) + (3) + (3) - (3) -(3) PB + CCl 4 +++ (4) ++++ (4) +++ (4) +++ (4) + (3), ++ (1) ++ (4) - (4) - ( (3) + (4) + (4) - (4) - (4) The histopathological changes were arbitrarily scored as follows: ( primary CYP isoform involved in CCl 4 bioactivation in rodents 16, 17 , although CYP2B isoforms may also be involved [18] [19] [20] . In rats, induction of CYP2E1 and 2B isoforms is correlated with increased susceptibility to CCl 4 as a result of the increased rate of CCl 4 metabolism 16, 19 . In the present study, the CCl 4 hepatotoxicities were remarkably enhanced in both lobes by pretreatment with PB, a potent inducer of CYP2B 21 . More specifically, the PB + CCl 4 treatment resulted in marked decreases in O-dealkylase activities in both lobes, with the extent of the decreases being stronger in the median lobe. Moreover, the extent of the lesions was also greater in the median lobe than in the left lobe. On the other hand, the CCl 4 hepatotoxicities were only slightly enhanced in both lobes by pretreatment with BNF, a potent inducer of CYP1A1 22 . This finding suggests the possibility that BNF-inducible CYP isoforms, mainly CYP1A1, are less likely to participate in the metabolism of CCl 4 . Therefore, the BNF + CCl 4 treatment resulted in only slight decreases in O-dealkylase activities in both lobes, with a similar distribution pattern to the BNF-alone group. Nevertheless, higher susceptibility to CCl 4 hepatotoxicities in the BNF + CCl 4 group was also observed in the median lobe. These results suggest that the heterogeneity of the CYP activities enhanced by PB pretreatment is closely correlated with the susceptibility to CCl 4 hepatotoxicities in different liver lobes, but that by BNF pretreatment is not. Specific CYP isoform measurements should provide further information on the correlation between the difference in the susceptibility to CCl 4 hepatotoxicities and the heterogeneity of CYP activities in the different liver lobes. Some factors other than the hepatic drug-metabolizing enzyme may participate in the lobar variation. There is a perception that blood returning from different abdominal organs does not mix completely but maintains a streamline flow in the human portal vein 23, 24 . Thus, the right extremity of the liver may chiefly receive blood from the superior mesenteric vein; the left lobe may receive blood from the left gastric (coronary), inferior mesenteric and splenic veins, whereas the left part of the right lobe, including the caudate and quadrate lobes, receives mixed blood. Copher and Dick 25 also demonstrated that the different oxygen tension in various lobes was dependent on unequal distribution of portal blood in dog liver lobes. If this were the case in the rat liver, the relative contribution of the hepatic artery and portal vein to the hepatic blood supply may have some role in CCl 4 hepatotoxicities, as it has been reported that a liver lobe denied portal blood, i.e., receiving blood only via the hepatic artery, suffered less severe damage from CCl 4 than other lobes receiving the dual blood supply 26 . In Addition, Towner et al. 27 reported CCl 4 -induced localized edematous regions surrounding the major branch of the hepatic portal vein in the right lobe of the rat liver using magnetic resonance imaging. These aspects are worthy of further study.
In conclusion, the present results show that the susceptibility of the median lobe to CCl 4 hepatotoxicities is apparently higher than that of the left lobe in rats pretreated with PB or BNF. Moreover, the heterogeneity of hepatic CYP activities enhanced by PB pretreatment was closely correlated with the susceptibility to CCl 4 hepatotoxicities in different liver lobes, although that by BNF pretreatment was not. Therefore, we suggest that the liver should not be regarded as a homogeneous organ in toxicological studies, and that the heterogeneity of hepatic CYP activities in the different liver lobes might be one of the factors causing the lobar variation of CCl 4 hepatotoxicities. Further studies are required to provide a satisfactory explanation for the cause of lobar variation.
